Home › Funds › Kathmere Capital Management, LLC › JNJ

Kathmere Capital Management, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Kathmere Capital Management, LLC reported holding 47,036 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$12.5M, representing 0.61% of its reported portfolio and ranking #33 among its reported holdings. Kathmere Capital Management, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)47.04K sh
Reported value held$12.45M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Kathmere Capital Management, LLC's JNJ position evolved

Kathmere Capital Management, LLC first disclosed a stake in JNJ in Q3 2023 at 15,865 shares (US$2.5M). The position peaked in Q3 2026 at 47,036 shares, worth US$12.5M. Across 13 filings, Kathmere Capital Management, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 47,036 shares valued at US$12.5M — an increase of 832 shares quarter over quarter.. Notable position changes include a 61% increase in Q3 2024 (shares fell 11% over the following quarter), a 46% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 15.87K $2.47M New
Q4 2023 12.61K $1.98M Reduce
Q1 2024 15.32K $2.42M Add
Q2 2024 15.28K $2.23M Hold
Q3 2024 24.62K $3.99M Add
Q4 2024 22.70K $3.28M Reduce
Q1 2025 33.14K $5.50M Add
Q2 2025 32.27K $4.93M Reduce
Q3 2025 36.47K $6.76M Add
Q4 2025 39.54K $8.18M Add
Q1 2026 43.81K $10.71M Add
Q2 2026 46.20K $11.73M Add
Q3 2026 47.04K $12.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Kathmere Capital Management, LLC held JNJ?

Kathmere Capital Management, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Kathmere Capital Management, LLC's current position in JNJ?

As of Q3 2026, Kathmere Capital Management, LLC holds 47.04K shares of JNJ (JOHNSON & JOHNSON), valued at $12.45M, representing 0.61% of its reported portfolio and ranking #33.

Has Kathmere Capital Management, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Kathmere Capital Management, LLC increased its position in JNJ. The position peaked in Q3 2026 at 47.04K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.